openPR Logo
Press release

Cardiac Biomarkers Market 2026 | Global Future Growth, Regional Development, Size, Industry Trends and 2026 Forecast

02-28-2020 09:46 AM CET | Health & Medicine

Press release from: Fortune Business Insights Private Limited

Cardiac Biomarkers Market

Cardiac Biomarkers Market

The acute coronary syndrome sub-segment under application segment is projected to dominate the global "cardiac biomarkers" market during the forecast period. It is likely to occur due to a rise in the investment by various health institutes in biomarker testing for early detection of the disease. This information is given in an upcoming report by Fortune Business Insights, titled, "Cardiac Biomarkers Market Size, Share and Global Trend By Type (Troponin, Creatine kinase-MB (CK-MB), B-type Natriuretic Peptide (BNP), and N-terminal pro b-type natriuretic peptide (NT-proBNP), Myoglobin), By Application (Acute Coronary Syndrome, Myocardial Infarction, Congestive Heart Failure), By End User (Hospitals, Diagnostic Centers, Homecare Settings) and Geography Forecast till 2026.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/cardiac-biomarkers-market-101233

The report provides market analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product & service launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis.

Key Companies and Manufacturers Covered:

o Thermo Fisher Scientific
o Abbott
o Becton
o Bio-Rad Laboratories, Inc.
o F. Hoffmann-La Roche Ltd.
o Randox Laboratories Ltd.
o Beckman Coulter, Inc.
o Dickinson and Company
o Dickinson and Company
o bioMrieux SA
o Other key market players

Siemens and Roche Receive FDA Clearance for Their Products to Aid in Early Detection of Heart Attack
Siemens Healthineers, a prominent healthcare company, based in Germany, announced in July 2018 that it bagged FDA approval for high-sensitivity troponin I assays (TnIH). They would be used on the company's Advia Centaur XP/XPT as well as Atellica IM immunoassay analyzers. It would further support in the early diagnosis of heart attacks or myocardial infarctions. Siemens declared that the two TnIH assays possess high sensitivity. Therefore, it would aid in detecting minute changes in troponin levels in patients as well as finding lower levels of troponin. The testing has to be conducted repeatedly to achieve the desired results. That is why doctors and clinicians would gain more confidence in the results and immediately begin treatment of the same.

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/cardiac-biomarkers-market-101233

Cardiac Biomarkers Market Segmentation:

By Type
o Troponin
o Creatine kinase-MB (CK-MB)
o B-type Natriuretic Peptide (BNP), and N-terminal pro b-type natriuretic peptide (NT-proBNP)
o Myoglobin
o Others
By Application
o Acute Coronary Syndrome
o Myocardial Infarction
o Congestive Heart Failure
o Others
By End User
o Hospitals
o Diagnostic Centers
o Homecare Settings
o Others
By Geography
o North America (USA and Canada)
o Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
o Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
o Latin America (Brazil, Mexico and Rest of Latin America)
o Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
Reasons to Purchase this Report:

o Detailed business profiles including product offerings, recent developments, key financial information, and strategies employed by main market players.
o Analysis of various regions and countries that includes the demand and supply based actions, which consequently have a major influence on the market's expansion.
o Market dynamics and opportunities for growth for players in the near future.
o Competitive landscape describing the market revenue shares of key players.
o Market segmentation analysis that deals with quantitative and qualitative research, discussing the influence of policy-based and economical aspects.

Our proven methodologies and systematic analysis help in making confident business and strategic decisions. A market study that conducts at Fortune Business Insights can save significant cost and time, and can help prevent making costly mistakes.

Order Full Report: https://www.fortunebusinessinsights.com/checkout-page/101233

About Us:

Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

Contact Us:
Fortune Business Insights(TM) Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Linkedin | Twitter | BLogs

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cardiac Biomarkers Market 2026 | Global Future Growth, Regional Development, Size, Industry Trends and 2026 Forecast here

News-ID: 1949226 • Views:

More Releases from Fortune Business Insights Private Limited

Forensic Technology Market Size, Share, Trends, Growth & Industry Overview [2025-2032]
Forensic Technology Market Size, Share, Trends, Growth & Industry Overview [2025 …
Forensic Technology Market: Trends, Growth, and Key Players in 2025 Market Overview The forensic technology market is undergoing a transformative evolution driven by advancements in AI, digitalization, and increasing global crime rates. From crime scene investigation to DNA analysis and digital forensics, modern forensic tools are revolutionizing law enforcement and judicial systems. As governments and private entities invest heavily in advanced forensic solutions, the market is poised for robust growth through 2032.
Dental Market Size, Share, Trends & Growth Report, 2032
Dental Market Size, Share, Trends & Growth Report, 2032
The global dental market size was valued at USD 37.86 billion in 2024. The market is projected to grow from USD 41.03 billion in 2025 to USD 87.65 billion by 2032, exhibiting a CAGR of 11.5% during the forecast period. North America dominated the dental market with a market share of 39.06% in 2024. The dental market refers to the industry that encompasses all businesses, products, and services related to oral
Contraceptives Market Growing Rapidly With a CAGR of 5.5% by 2027
Contraceptives Market Growing Rapidly With a CAGR of 5.5% by 2027
🌍 Contraceptives Market: Global Industry Insights, Trends & Forecast to 2027 🤖 Market Overview The global contraceptives market has seen consistent growth over the past decade, driven by increased awareness around reproductive health, government initiatives promoting family planning, and technological advancements in birth control methods. As we move toward 2027, the market is projected to witness significant expansion, presenting lucrative opportunities for stakeholders, manufacturers, and investors. This article offers a comprehensive analysis of
Smart Inhalers Market Size, Share, Growth & Industry Report (2025-2032)
🌐 Market Overview The smart inhalers market is poised for exponential growth, driven by increasing respiratory disorders, advancements in digital health, and the demand for personalized treatment. Smart inhalers, equipped with sensors and Bluetooth technology, help patients track dosage, adherence, and treatment effectiveness in real time. These devices are increasingly integrated with mobile health apps, improving both patient outcomes and physician monitoring. With healthcare systems shifting toward remote patient management, smart

All 5 Releases


More Releases for Cardiac

Cardiac Resynchronization Therapy: Driving Innovation and Transforming Global Ca …
London, UK - August 2025 | Strategic Revenue Insights Inc. The global cardiac resynchronization therapy (CRT) market is emerging as one of the most crucial sectors in cardiovascular healthcare, offering life-saving solutions for patients with heart failure and conduction abnormalities. CRT devices, including pacemakers and defibrillators, are designed to restore synchronized heart contractions, significantly improving patient survival rates and quality of life. With rising cardiovascular disease prevalence worldwide, CRT has
Mobile Cardiac Telemetry Systems Market Redefining Remote Cardiac Monitoring
"In recent years, the global Mobile Cardiac Telemetry Systems Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Mobile Cardiac Telemetry Systems Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot
Ambulatory Cardiac Monitoring Devices Market: Revolutionizing Cardiac Care
In the rapidly evolving landscape of healthcare, the Ambulatory Cardiac Monitoring Devices Market stands out as a beacon of innovation and progress. These devices, including ECG devices, Holter monitors, event monitors, implantable loop recorders, and mobile cardiac telemetry, have become indispensable tools for healthcare professionals in managing and diagnosing cardiac conditions. As heart-related issues continue to afflict millions globally, the demand for advanced cardiac monitoring solutions is on the rise. Request
Cardiac Monitoring & Cardiac Rhythm Management Devices Market - Precision Monito …
Newark, New Castle, USA: The "Cardiac Monitoring & Cardiac Rhythm Management Devices Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Cardiac Monitoring & Cardiac Rhythm Management Devices
Cardiac Monitoring & Cardiac Rhythm Management Device Market
According to a new market research report published by Global Market Estimates, the Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market is expected to grow at a CAGR of 3.88% during the forecast period. The increasing occurrence of dyslipidemia, hypertension, and rising demand for cardiac monitoring & cardiac rhythm management devices to save patients at a huge risk of cardiac arrest. Browse 145 Market Data Tables and 119 Figures spread
Global Cardiac Monitoring & Cardiac Rhythm Management Market Insights, Forecast
Cardiac monitoring (CM) devices help in continuous examination of a patient’s cardiac activity. Cardiac rhythm management (CRM) devices maintain normal cardiac rhythm in patients suffering from rate and rhythm disorders of the heart. These devices play a crucial role in the treatment of serious cardiac disorders, including heart failure, atrial fibrillation, atrial flutter, indications of recent heart attack, coronary ischemia, lack of oxygen supply to cardiac muscles, effects of drugs,